161 related articles for article (PubMed ID: 31261558)
1. Prognostic biomarkers of cervical squamous cell carcinoma identified via plasma metabolomics.
Zhou H; Li Q; Wang T; Liang H; Wang Y; Duan Y; Song M; Wang Y; Jin H
Medicine (Baltimore); 2019 Jun; 98(26):e16192. PubMed ID: 31261558
[TBL] [Abstract][Full Text] [Related]
2. Screening by Q Exactive liquid chromatography/tandem mass spectrometry identified Choline, 25-hydroxyvitamin D2, and SM(d18:0/16:1(9Z) (OH)) as biomarkers for high-grade serous ovarian cancer.
Li J; Liu D; Cui M; Wei Z
J Proteomics; 2024 May; 299():105154. PubMed ID: 38471622
[TBL] [Abstract][Full Text] [Related]
3. Exploring metabolomics biomarkers for evaluating the effectiveness of concurrent radiochemotherapy for cervical cancers.
Zhou H; Li Q; Wang T; Liang H; Wang Y; Duan Y; Song M; Wang Y; Jin H
Transl Cancer Res; 2020 Apr; 9(4):2734-2747. PubMed ID: 35117632
[TBL] [Abstract][Full Text] [Related]
4. Global and targeted metabolomics of esophageal squamous cell carcinoma discovers potential diagnostic and therapeutic biomarkers.
Xu J; Chen Y; Zhang R; Song Y; Cao J; Bi N; Wang J; He J; Bai J; Dong L; Wang L; Zhan Q; Abliz Z
Mol Cell Proteomics; 2013 May; 12(5):1306-18. PubMed ID: 23397110
[TBL] [Abstract][Full Text] [Related]
5. Metabolomics of papillary thyroid carcinoma tissues: potential biomarkers for diagnosis and promising targets for therapy.
Shang X; Zhong X; Tian X
Tumour Biol; 2016 Aug; 37(8):11163-75. PubMed ID: 26935059
[TBL] [Abstract][Full Text] [Related]
6. Serum metabolomic signatures of lymph node metastasis of esophageal squamous cell carcinoma.
Jin H; Qiao F; Chen L; Lu C; Xu L; Gao X
J Proteome Res; 2014 Sep; 13(9):4091-103. PubMed ID: 25162382
[TBL] [Abstract][Full Text] [Related]
7. [Plasma metabolomics in a deep vein thrombosis rat model based on ultra-high performance liquid chromatography-electrostatic field orbitrap high resolution mass spectrometry].
Gu Y; Zang P; Li J; Yan Y; Wang J
Se Pu; 2022 Aug; 40(8):736-745. PubMed ID: 35903841
[TBL] [Abstract][Full Text] [Related]
8. Integrated tissue proteome and metabolome reveal key elements and regulatory pathways in cutaneous squamous cell carcinoma.
Chen W; Rao J; Liu Z; You X; Yuan F; Le F; Tang M; Zhou M; Xie T
J Proteomics; 2021 Sep; 247():104320. PubMed ID: 34237460
[TBL] [Abstract][Full Text] [Related]
9. [Screening of serum oxysterol biomarkers for colon cancer by liquid chromatography-tandem mass spectrometry].
Ma Z; Li Z; Wang H; Wang R; Han X
Se Pu; 2022 Jun; 40(6):541-546. PubMed ID: 35616199
[TBL] [Abstract][Full Text] [Related]
10. Serum metabolic profiling analysis of gout patients based on UPLC-Q-TOF/MS.
Zhong Z; Huang Y; Huang Q; Zheng S; Huang Z; Deng W; Li T
Clin Chim Acta; 2021 Apr; 515():52-60. PubMed ID: 33388309
[TBL] [Abstract][Full Text] [Related]
11. Identification of phosphatidylcholine and lysophosphatidylcholine as novel biomarkers for cervical cancers in a prospective cohort study.
Yin MZ; Tan S; Li X; Hou Y; Cao G; Li K; Kou J; Lou G
Tumour Biol; 2016 Apr; 37(4):5485-92. PubMed ID: 26566624
[TBL] [Abstract][Full Text] [Related]
12. [Lipid metabolomic analysis in exosomes of osteonecrosis of the femoral head based on ultra performance liquid chromatography-tandem mass spectrometry].
Guo M; Zhang J
Se Pu; 2022 Feb; 40(2):123-129. PubMed ID: 35080158
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of differences between unifloral honeys from different botanical origins based on non-targeted metabolomics by ultra-high performance liquid chromatography-quadrupole time-of-flight mass spectrometry].
Shen S; Yang Y; Wang J; Chen X; Liu T; Zhuo Q
Se Pu; 2021 Mar; 39(3):291-300. PubMed ID: 34227310
[TBL] [Abstract][Full Text] [Related]
14. Early Breast Cancer Detection Using Untargeted and Targeted Metabolomics.
Wei Y; Jasbi P; Shi X; Turner C; Hrovat J; Liu L; Rabena Y; Porter P; Gu H
J Proteome Res; 2021 Jun; 20(6):3124-3133. PubMed ID: 34033488
[TBL] [Abstract][Full Text] [Related]
15. Novel serum metabolomics-based approach by gas chromatography/triple quadrupole mass spectrometry for detection of human skin cancers: Candidate biomarkers.
Fukumoto T; Nishiumi S; Fujiwara S; Yoshida M; Nishigori C
J Dermatol; 2017 Nov; 44(11):1268-1275. PubMed ID: 28593747
[TBL] [Abstract][Full Text] [Related]
16. Predicting ovarian cancer recurrence by plasma metabolic profiles before and after surgery.
Zhang F; Zhang Y; Ke C; Li A; Wang W; Yang K; Liu H; Xie H; Deng K; Zhao W; Yang C; Lou G; Hou Y; Li K
Metabolomics; 2018 Apr; 14(5):65. PubMed ID: 30830339
[TBL] [Abstract][Full Text] [Related]
17. Discovery of potential biomarkers in acute kidney injury by ultra-high-performance liquid chromatography-tandem quadrupole time-of-flight mass spectrometry (UPLC-Q/TOF-MS).
Chen C; Zhang P; Bao G; Fang Y; Chen W
Int Urol Nephrol; 2021 Dec; 53(12):2635-2643. PubMed ID: 33686532
[TBL] [Abstract][Full Text] [Related]
18. Identification of plasma metabolomic profiling for diagnosis of esophageal squamous-cell carcinoma using an UPLC/TOF/MS platform.
Liu R; Peng Y; Li X; Wang Y; Pan E; Guo W; Pu Y; Yin L
Int J Mol Sci; 2013 Apr; 14(5):8899-911. PubMed ID: 23615477
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of post-radiation serum squamous cell carcinoma antigen and primary tumor regression for cervical squamous cell carcinoma.
Wan Q; Yan W; Liu Y; Lin Y; Lu Z
Cancer Biomark; 2020; 29(3):327-335. PubMed ID: 32716344
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]